News | Mammography | October 27, 2021

Screenings offered between Oct. 18 and Oct. 29 at a local school in North Philadelphia, build on Penn Medicine’s commitment to improving care and outcomes among low-income and minority patients 

FREE 3D Mobile Mammograms in North Philadelphia provided by Penn Medicine and Siemens Healthineers. Image courtesy of Penn Medicine


October 27, 2021 — As part of Breast Cancer Awareness Month, Penn Medicine will be providing free breast cancer screenings, no insurance required, to women in need over the age of 40. A Siemens Healthineers 54-foot-long mobile mammography unit featuring the company’s MAMMOMAT Revelation digital mammography system, accredited by the American College of Radiology, will roll into the West Lehigh neighborhood of North Philadelphia to offer 3D mammograms. Staff on the screening bus, located in the Save-A-Lot parking lot across from The Murrell Dobbins Career and Technical Education High School at 2101 W. Lehigh Ave., will provide individual 10-minute screening exams, a private changing room, and Spanish translation services. The screening event will be held on weekdays from Monday, Oct. 18 through Friday, Oct. 29, from 9 a.m. to 7 p.m.

“Cancer disproportionately impacts lower socioeconomic groups and the medically underserved because they are unable to access cancer screening tests, and thus more likely to be diagnosed with late stage cancer,” Carmen Guerra, M.D., Vice Chair of Diversity and Inclusion, Department of Medicine at University of Pennsylvania “This mobile mammography initiative is one of many efforts we have committed for engaging underserved communities with access to important healthcare resources and education.”

Only about half (54 percent) of breast cancers in Black women are diagnosed at an early stage, when they’re most likely to be treated successfully, compared to 64 percent of cancers detected early in white women. The delays have wide-reaching effects for survival: only 81 percent of Black women diagnosed with breast cancer live to five years after their diagnosis, compared to 91 percent among white women with the disease.

The Siemens Healthineers screening partnership adds to the Abramson Cancer Center’s suite of programs and efforts to eliminate disparities in cancer detection, care, and outcomes among low-income and minority communities.  The Penn Medicine Breast Health Initiative, for instance, aims to boost rates of early detection and treatment through patient navigation and breast health education, help signing up for health insurance, language interpreters at appointments, and public transportation tokens to assist in getting to and from appointments. The Siemens Healthineers system allows women to receive a full 3D screening exam with technology designed to offer comfortable examinations with less compression.

Improving representation of minority patients in clinical trials is another important tactic to narrowing the gaps in cancer outcomes. A five-year community outreach and engagement effort by the Abramson Cancer Center (ACC) – which included partnerships with faith-based organizations, community centers and health centers – doubled the percentage of Black participants in clinical trials, improving access and treatment for a group with historically low representation in cancer research and helping pave a path for more effective treatments and chances at a cure.

Penn Medicine radiologists will review all imaging taken during the mobile mammogram event and receive information and counseling for any further evaluation or care which may be needed. The event will include educational sessions for Murrell Dobbins students to learn about the importance of annual mammography, what it takes to become a certified imaging technician, and more about the field.

For more information: www.med.upenn.edu/

Related Breast Imaging Information:

Black Women Face Three-fold Increased Risk of Triple Negative Breast Cancers

Black Women Are Receiving Inferior Breast Screening

Hologic Partners with Oprah Winfrey Network to Combat Health Disparities for Black Women

Legislation May Help Identify Breast Cancer Earlier in Certain At-risk Women

Female Breast Cancer Surpasses Lung as the Most Commonly Diagnosed Cancer Worldwide

Johns Hopkins Medicine Expert Weighs Devastating Impact of COVID-19 on Healthcare Workers

Radiation Oncologists Urge Congress to Advance Bills That Protect Patient Access to Cancer Care During Pandemic

Breast Imaging in the Age of Coronavirus

 


Related Content

Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Breast Density | By Robert L. Bard, MD

Decades since the advent of breast scanning technology, innovations in noninvasive diagnostic imaging provide new ...

Time May 03, 2024
arrow
News | Breast Imaging

May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast ...

Time May 01, 2024
arrow
News | Breast Imaging

May 1, 2024 — After the issuance of updated breast screening recommendations by the U.S. Preventive Services Task Force ...

Time May 01, 2024
arrow
Feature | Breast Imaging | Christine Book

April 30, 2024 — The U.S. Preventive Services Task Force (Task Force) today published a final recommendation statement ...

Time April 30, 2024
arrow
Feature | Breast Imaging | By Christine Book

From implementing artificial intelligence effectively, advocating for radiologists, and working tirelessly to expand ...

Time April 29, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Subscribe Now